Show simple item record

dc.contributor.authorSağ, Elif
dc.contributor.authorDurmaz, Özlem
dc.contributor.authorÖnal, Zerrin
dc.contributor.authorTuğcu, Deniz
dc.contributor.authorYücel, Esra
dc.contributor.authorYılmaz, Tuğçe
dc.contributor.authorLeblebici, Uğur Can
dc.date.accessioned2023-10-10T10:49:01Z
dc.date.available2023-10-10T10:49:01Z
dc.identifier.citationYılmaz T., Leblebici U. C., Önal Z., Sağ E., Tuğcu D., Yücel E., Durmaz Ö., "RITUXIMAB IN DIFFICULT-TO-MANAGE IMMUNE-MEDIATED LIVER DISEASES: IS IT SAFE AND EFFECTIVE?", ESPGHAN 55th Annual Meeeting, Vienna, Avusturya, 17 - 20 Mayıs 2023, ss.915
dc.identifier.othervv_1032021
dc.identifier.otherav_0d0921a7-13b7-4f0a-aab8-1d2eaa725353
dc.identifier.urihttp://hdl.handle.net/20.500.12627/189523
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.titleRITUXIMAB IN DIFFICULT-TO-MANAGE IMMUNE-MEDIATED LIVER DISEASES: IS IT SAFE AND EFFECTIVE?
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.contributor.firstauthorID4574619


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record